Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)

Sam Chun Dang Pharm. Revenue

Sam Chun Dang Pharm. had revenue of 70.74B KRW in the quarter ending June 30, 2026, with 24.33% growth. This brings the company's total for the last twelve months to 259.90B, up 20.83% year-over-year. In the year 2025, Sam Chun Dang Pharm. had annual revenue of 231.81B with 9.90% growth. That makes Sam Chun Dang Pharm. the 17,623rd largest company in the world by revenue and 900th in South Korea.

• Revenue (ttm): 259.90B
• Revenue Growth: +20.83%
• P/S Ratio: 17.01
• Revenue / Employee: 614.42M
• Employees: 423
• Market Cap: 4.42T

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 202.99B 87.6%
• Overseas 28.81B 12.4%

Fiscal year ended Dec 31, 2025 See the full Sam Chun Dang Pharm. breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	231.81B	20.88B	9.90%
Dec 31, 2024	210.92B	18.26B	9.47%
Dec 31, 2023	192.67B	15.33B	8.65%
Dec 31, 2022	177.34B	10.06B	6.01%
Dec 31, 2021	167.27B	412.57M	0.25%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error